David Asuzu1, Karin Nyström2, Hardik Amin2, Joseph Schindler3,2, Charles Wira3,2, David Greer3,2, Nai Fang Chi4, Janet Halliday2, Kevin N Sheth5,6. 1. Department of Neurology, Yale School of Medicine, 15 York Street, LCI 10, New Haven, CT, 06510, USA. david.asuzu@yale.edu. 2. Division of Vascular Neurology, Division of Neurocritical Care and Emergency Neurology, Yale Department of Emergency Medicine, Yale Department of Neurology, Yale-New Haven Hospital, New Haven, CT, USA. 3. Department of Neurology, Yale School of Medicine, 15 York Street, LCI 10, New Haven, CT, 06510, USA. 4. Department of Neurology, Taipei Medical University Hospital and Shuang Ho Hospital, Taipei, Taiwan. 5. Department of Neurology, Yale School of Medicine, 15 York Street, LCI 10, New Haven, CT, 06510, USA. kevin.sheth@yale.edu. 6. Division of Vascular Neurology, Division of Neurocritical Care and Emergency Neurology, Yale Department of Emergency Medicine, Yale Department of Neurology, Yale-New Haven Hospital, New Haven, CT, USA. kevin.sheth@yale.edu.
Abstract
INTRODUCTION: Symptomatic intracranial hemorrhage (sICH) is a serious complication of IV rt-PA therapy after acute ischemic stroke. Independent sICH predictors have been previously derived using case-control studies. Here we utilized a novel cohort-based comparison to identify additional independent predictors of sICH. METHODS: We included 210 patients receiving IV rt-PA therapy from January 2009 through December 2013 at the Yale-New Haven Stroke Center. Clinical parameters were compared using Mann-Whitney tests, two-sample tests of proportions and two-sample t tests. Logistic regression was performed using sICH as the dependent variable. Predictive ability was assessed using areas under the receiver operating characteristic (ROC) curve. RESULTS: sICH rates were lowest from 2010 to 2012 and comprised the low sICH cohort (2.0 % sICH), compared to the high sICH cohort from 2009 to 2013 (9.2 % sICH, P = 0.025). Patients in the low sICH cohort had significantly more visual field deficits (38.6 vs. 24.8 %, P = 0.03) and decreased levels of consciousness (62.4 vs. 39.4 %, P < 0.001), but fewer hyperdense MCA signs (5 vs. 13.8 %, P = 0.03) and early CT hypodensities (14.9 vs. 29.4 %, P = 0.01). These four parameters together predicted sICH modestly (area under ROC curve 0.66, odds ratio 2.72, P = 0.03) CONCLUSIONS: Using a novel cohort-based approach, we identified two new independent predictors of sICH after IV rt-PA therapy: the presence of the hyperdense MCA sign and early CT hypodensities. Novel methods are needed to reduce the risk of sICH for patients receiving antithrombolytic therapy for ischemic stroke.
INTRODUCTION: Symptomatic intracranial hemorrhage (sICH) is a serious complication of IV rt-PA therapy after acute ischemic stroke. Independent sICH predictors have been previously derived using case-control studies. Here we utilized a novel cohort-based comparison to identify additional independent predictors of sICH. METHODS: We included 210 patients receiving IV rt-PA therapy from January 2009 through December 2013 at the Yale-New Haven Stroke Center. Clinical parameters were compared using Mann-Whitney tests, two-sample tests of proportions and two-sample t tests. Logistic regression was performed using sICH as the dependent variable. Predictive ability was assessed using areas under the receiver operating characteristic (ROC) curve. RESULTS: sICH rates were lowest from 2010 to 2012 and comprised the low sICH cohort (2.0 % sICH), compared to the high sICH cohort from 2009 to 2013 (9.2 % sICH, P = 0.025). Patients in the low sICH cohort had significantly more visual field deficits (38.6 vs. 24.8 %, P = 0.03) and decreased levels of consciousness (62.4 vs. 39.4 %, P < 0.001), but fewer hyperdense MCA signs (5 vs. 13.8 %, P = 0.03) and early CT hypodensities (14.9 vs. 29.4 %, P = 0.01). These four parameters together predicted sICH modestly (area under ROC curve 0.66, odds ratio 2.72, P = 0.03) CONCLUSIONS: Using a novel cohort-based approach, we identified two new independent predictors of sICH after IV rt-PA therapy: the presence of the hyperdense MCA sign and early CT hypodensities. Novel methods are needed to reduce the risk of sICH for patients receiving antithrombolytic therapy for ischemic stroke.
Entities:
Keywords:
IV Thrombolysis; Intracerebral hemorrhage; Neurocritical care
Authors: Timothy John Ingall; William Michael O'Fallon; Kjell Asplund; Lewis Robert Goldfrank; Vicki S Hertzberg; Thomas Arthur Louis; Teresa J Hengy Christianson Journal: Stroke Date: 2004-09-02 Impact factor: 7.914
Authors: W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas Journal: Lancet Date: 1998-10-17 Impact factor: 79.321
Authors: David Asuzu; Karin Nystrom; Hardik Amin; Joseph Schindler; Charles Wira; David Greer; Nai Fang Chi; Janet Halliday; Kevin N Sheth Journal: Neurocrit Care Date: 2015-04 Impact factor: 3.210
Authors: David Asuzu; Karin Nyström; Joseph Schindler; Charles Wira; David Greer; Janet Halliday; Kevin N Sheth Journal: Neurocrit Care Date: 2015-10 Impact factor: 3.210
Authors: Tomáš Dorňák; Michal Král; Zuzana Sedláčková; Daniel Šaňák; Eva Čecháková; Petra Divišová; Jana Zapletalová; Petr Kaňovský Journal: Transl Stroke Res Date: 2018-01-15 Impact factor: 6.829
Authors: David Asuzu; Karin Nyström; Anirudh Sreekrishnan; Joseph Schindler; Charles Wira; David Greer; Janet Halliday; W Taylor Kimberly; Kevin N Sheth Journal: Neurocrit Care Date: 2016-06 Impact factor: 3.210